Literature DB >> 11180689

Trends in passive smoking in cystic fibrosis, 1993-1998.

A Smyth1, U O'Hea, C Feyerabend, S Lewis, R Smyth.   

Abstract

We set out to study trends in exposure to passive smoking in children with cystic fibrosis over a 5-year period. We also evaluated the effects of this exposure on lung function. Cross-sectional data were collected on 52 children in 1998 and compared with similar data collected on 56 children in 1993. Within these two groups, there were 34 children who were studied on both occasions. Data collected included: questionnaire information about family smoking habits; forced expiratory volume in 1 sec (FEV1); forced vital capacity (FVC); and measurements of urinary and salivary cotinine levels. Salivary cotinine was more closely related to family smoking behavior than urinary cotinine concentrations (r for salivary cotinine = 0.54, P < 0.001; r for urinary cotinine = 0.37, P = 0.008). In 1993, 26/56 (46%) households contained at least one smoker (smoking households) compared with 23/52 (44%) in 1998. In 1993, a median of 15 cigarettes was smoked/day in smoking households compared to 20 cigarettes/day in 1998. In the longitudinal group, there was a small, nonsignificant reduction in mean urinary cotinine levels (geometric mean, 1993 = 5.03 ng/mL; 1998 = 4.76 ng/mL; P = 0.4). There was no significant difference between the smoking and nonsmoking households in change in lung function over 5 years (fall in FEV1 in smoking households, 10.3% vs. 11.2% in nonsmoking households; P = 0.87). We conclude that in a group of children with cystic fibrosis followed over 5 years, there was little reduction in passive smoking exposure. We did not show a relationship between such exposure and decline in lung function. A larger study will be necessary to determine whether such an effect is present. .

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180689     DOI: 10.1002/1099-0496(200102)31:2<133::aid-ppul1021>3.0.co;2-8

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  5 in total

1.  Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.

Authors:  J Michael Collaco; Lori Vanscoy; Lindsay Bremer; Kathryn McDougal; Scott M Blackman; Amanda Bowers; Kathleen Naughton; Jacky Jennings; Jonathan Ellen; Garry R Cutting
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

2.  Occupational exposures, smoking and airway inflammation in refractory asthma.

Authors:  Jodie L Simpson; Maya Guest; May M Boggess; Peter G Gibson
Journal:  BMC Pulm Med       Date:  2014-12-19       Impact factor: 3.317

3.  Evaluating environmental tobacco smoke exposure in a group of Turkish primary school students and developing intervention methods for prevention.

Authors:  Hasan C Ekerbicer; Mustafa Celik; Ekrem Guler; Mehmet Davutoglu; Metin Kilinc
Journal:  BMC Public Health       Date:  2007-08-10       Impact factor: 3.295

Review 4.  The Impact of Secondhand Smoke Exposure on Children with Cystic Fibrosis: A Review.

Authors:  Benjamin T Kopp; Juan Antonio Ortega-García; S Christy Sadreameli; Jack Wellmerling; Estelle Cormet-Boyaka; Rohan Thompson; Sharon McGrath-Morrow; Judith A Groner
Journal:  Int J Environ Res Public Health       Date:  2016-10-12       Impact factor: 3.390

5.  Ozone is associated with an increased risk of respiratory exacerbations in patients with cystic fibrosis.

Authors:  Sylvia C L Farhat; Marina B Almeida; Luiz Vicente R F Silva-Filho; Juliana Farhat; Joaquim C Rodrigues; Alfésio L F Braga
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.